Complete genome sequence of an M1 strain of Streptococcus pyogenes

Complete genome sequence of an M1 strain of Streptococcus pyogenes

April 10, 2001 | Joseph J. Ferretti*, William M. McShan*, Dragana Adjic*, Dragutin J. Savic*, Gorana Savic*, Kevin Lyon*, Charles Primeaux*, Steven Sezate*, Alexander N. Suvorov**, Steve Kenton§, Hong Shing Lai§, Shao Ping Lin§, Yudong Qian§, Hong Gui Jia§, Fares Z. Najar§, Qun Ren§, Hua Zhu§, Lin Song§, Jim White§, Xiling Yuan§, Sandra W. Clifton§¶, Bruce A. Roe§, and Robert McLaughlin*
The complete genome sequence of an M1 strain of Streptococcus pyogenes (group A streptococci, GAS) has been determined, revealing a 1,852,442-bp genome containing 1,752 predicted protein-encoding genes. Approximately one-third of these genes have no known function, while the remainder are associated with known microbial functions. Over 40 putative virulence-associated genes have been identified, along with genes involved in molecular mimicry and diseases like rheumatic fever and acute glomerulonephritis. Four bacteriophage genomes are also present, each containing genes for previously undiscovered superantigen-like proteins, which may contribute to the pathogenic potential of GAS. S. pyogenes is a strict human pathogen responsible for various diseases, including pharyngitis, scarlet fever, impetigo, and severe infections like necrotizing fasciitis. It is classified into two classes based on postinfectious sequelae: class I (rheumatic fever) and class II (acute glomerulonephritis). The genome sequence was determined using whole-genome shotgun methods and assembled with high accuracy. The genome is circular, with an average G+C content of 38.5%, and contains a variety of genes involved in metabolism, transport, and virulence. The genome includes genes for several bacteriocin-like peptides, including salivaricin A and streptolysin S. It also contains genes for superantigen-like proteins, many of which are associated with mobile genetic elements. The genome has 36 ABC transporters, including those for iron, phosphate, and amino acid uptake. Additionally, the genome contains genes for several virulence factors, including those involved in molecular mimicry and immune evasion. Horizontal gene transfer, particularly through bacteriophages, is a significant factor in the evolution and pathogenicity of GAS. The genome contains genes for several transposons and insertion sequences, some of which are associated with virulence. The presence of these mobile genetic elements suggests that GAS may acquire new virulence traits through horizontal gene transfer. The genome also contains genes for various regulatory systems, including sigma factors and two-component regulators, which are essential for stress responses and virulence. The genome includes genes for several stress-related proteins, including proteases and components of the SOS regulon, which are involved in DNA repair and stress response. The study provides insights into the genetic basis of GAS pathogenicity and highlights the importance of bacteriophages and horizontal gene transfer in the evolution of this pathogen. The complete genome sequence of this M1 strain of S. pyogenes is a valuable resource for understanding the molecular mechanisms underlying GAS infections and for developing new strategies for vaccine development and treatment.The complete genome sequence of an M1 strain of Streptococcus pyogenes (group A streptococci, GAS) has been determined, revealing a 1,852,442-bp genome containing 1,752 predicted protein-encoding genes. Approximately one-third of these genes have no known function, while the remainder are associated with known microbial functions. Over 40 putative virulence-associated genes have been identified, along with genes involved in molecular mimicry and diseases like rheumatic fever and acute glomerulonephritis. Four bacteriophage genomes are also present, each containing genes for previously undiscovered superantigen-like proteins, which may contribute to the pathogenic potential of GAS. S. pyogenes is a strict human pathogen responsible for various diseases, including pharyngitis, scarlet fever, impetigo, and severe infections like necrotizing fasciitis. It is classified into two classes based on postinfectious sequelae: class I (rheumatic fever) and class II (acute glomerulonephritis). The genome sequence was determined using whole-genome shotgun methods and assembled with high accuracy. The genome is circular, with an average G+C content of 38.5%, and contains a variety of genes involved in metabolism, transport, and virulence. The genome includes genes for several bacteriocin-like peptides, including salivaricin A and streptolysin S. It also contains genes for superantigen-like proteins, many of which are associated with mobile genetic elements. The genome has 36 ABC transporters, including those for iron, phosphate, and amino acid uptake. Additionally, the genome contains genes for several virulence factors, including those involved in molecular mimicry and immune evasion. Horizontal gene transfer, particularly through bacteriophages, is a significant factor in the evolution and pathogenicity of GAS. The genome contains genes for several transposons and insertion sequences, some of which are associated with virulence. The presence of these mobile genetic elements suggests that GAS may acquire new virulence traits through horizontal gene transfer. The genome also contains genes for various regulatory systems, including sigma factors and two-component regulators, which are essential for stress responses and virulence. The genome includes genes for several stress-related proteins, including proteases and components of the SOS regulon, which are involved in DNA repair and stress response. The study provides insights into the genetic basis of GAS pathogenicity and highlights the importance of bacteriophages and horizontal gene transfer in the evolution of this pathogen. The complete genome sequence of this M1 strain of S. pyogenes is a valuable resource for understanding the molecular mechanisms underlying GAS infections and for developing new strategies for vaccine development and treatment.
Reach us at info@study.space